AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With COVID-19 (Trial H4: AZD7442)
1 other identifier
interventional
1,455
9 countries
124
Brief Summary
This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either a AZD7442 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H4.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 covid19
Started Feb 2021
Longer than P75 for phase_3 covid19
124 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2022
CompletedFirst Submitted
Initial submission to the registry
March 20, 2023
CompletedFirst Posted
Study publicly available on registry
March 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2023
CompletedResults Posted
Study results publicly available
July 30, 2024
CompletedFebruary 4, 2025
January 1, 2025
12 months
March 20, 2023
January 31, 2024
January 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants With Sustained Recovery
The primary endpoint is the proportion of subjects with sustained recovery, which is defined as being discharged from the index hospitalization, followed by being alive and home for 14 consecutive days prior to Day 90. Home is defined as the level of residence or facility where the participant was residing prior to hospital admission leading to enrollment in this protocol. Readmission from "home" may occur, and if this occurs within 14 days of the first discharge to "home," then the primary endpoint will not be reached until such time as the participant has been at home for 14 consecutive days.
Through Day 90
Number of Participants With an Ordinal Outcome on Day 5
Ordinal outcome with 7 mutually exclusive categories
Status on Day 5
Secondary Outcomes (4)
Number of Participants With a Safety Outcome Through Day 5
Through Day 5
Number of Participants With a Safety Outcome Through Day 28
Through Day 28
Number of Participants With a Safety Outcome Through Day 90
Through Day 90
Number of Participants Who Died From All Causes
Through Day 90
Study Arms (2)
AZD7442 plus SOC
EXPERIMENTAL* AZD7442 600 mg solution (4 separate vials, 2 containing 150 mg each of AZD88995 and 2 containing 150 mg each of AZD1061); administered by IV infusion * Remdesivir is provided to all study participants as SOC unless contraindicated for an individual patient; administered by IV infusion
Placebo plus SOC
PLACEBO COMPARATOR* Placebo administered by IV infusion * Remdesivir is provided to all study participants as SOC unless contraindicated for an individual patient; administered by IV infusion
Interventions
AZD8895 and AZD1061, known collectively as AZD7442, are two fully human neutralizing immunoglobulin G (IgG)-1 kappa monoclonal antibodies (mAb) that target two distinct epitopes on the receptor-binding domain of the spike protein of SARS-CoV- 2.
Eligibility Criteria
You may qualify if:
- Refer to the master protocol (NCT04501978)
You may not qualify if:
- Refer to the master protocol (NCT04501978)
- Pregnant women
- Nursing mothers
- Women of child-bearing potential who are unwilling to acknowledge the strong advice to abstain from sexual intercourse with men or practice appropriate contraception through the entire 18 months of the study
- Men who are unwilling to acknowledge the strong advice to abstain from sexual intercourse with women of child-bearing potential or to use barrier contraception through the entire 18 months of the study.
- In addition, prior to the initial futility assessment which is performed when approximately 150 participants have been enrolled on AZD7442 and 150 on placebo, patients on high-flow oxygen or non-invasive ventilation (category 5 of the pulmonary ordinal outcome) will be excluded. These patients may be eligible for the trial if the initial futility assessment is passed by this agent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID)lead
- International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)collaborator
- University of Copenhagencollaborator
- Medical Research Councilcollaborator
- Kirby Institutecollaborator
- Washington D.C. Veterans Affairs Medical Centercollaborator
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infectionscollaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
- US Department of Veterans Affairscollaborator
- Prevention and Early Treatment of Acute Lung Injurycollaborator
- Cardiothoracic Surgical Trials Networkcollaborator
- AstraZenecacollaborator
- University of Minnesotacollaborator
Study Sites (124)
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
Tucson, Arizona, 85719, United States
Southern Arizona VA Healthcare System (Site 074-009), 3601 S. 6th Ave.
Tucson, Arizona, 85723, United States
Velocity Chula Vista (Site 080-034), 752 Medical Center Ct., Ste. 304
Chula Vista, California, 91911, United States
Community Regional Medical Center (Site 203-005), 2823 Fresno Street
Fresno, California, 93701, United States
Velocity San Diego (Site 080-035), 5565 Grossmont Center Drive, Building 2, Suite 1
La Mesa, California, 91942, United States
VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street
Loma Linda, California, 92357, United States
VA Long Beach Healthcare System (Site 074-026), 5901 East 7th Street (09/151-M2)
Long Beach, California, 90822, United States
Keck Hospital of USC (Site 301-020), 1500 San Pablo Street
Los Angeles, California, 90033, United States
Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Blvd.
Los Angeles, California, 90048, United States
Ronald Reagan UCLA Medical Center (Site 203-002), 757 Westwood Plaza
Los Angeles, California, 90095, United States
Sacramento VA Medical Center (Site 074-023), 10535 Hospital Way
Mather, California, 95655, United States
Hoag Memorial Hospital Presbyterian (Site 080-026), One Hoag Drive
Newport Beach, California, 92663, United States
VA San Diego Healthcare System (Site 074-016), 3350 La Jolla Village Drive
San Diego, California, 92161, United States
UCSF Medical Center at Mount Zion (Site 203-007), 1600 Divisadero St.
San Francisco, California, 94115, United States
San Francisco VAMC (Site 074-002), 4150 Clement St.
San Francisco, California, 94121, United States
UCSF Medical Center (Site 203-001), Moffitt-Long Hospital, 505 Parnassus Ave.
San Francisco, California, 94143, United States
Stanford University Hospital & Clinics (Site 203-003), 300 Pasteur Dr.
Stanford, California, 94305, United States
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (Site 066-002), 1124 W. Carson Street, CDCRC Building
Torrance, California, 90502, United States
University of Colorado Hospital (Site 204-001), 12605 E. 16th Avenue
Aurora, Colorado, 80045, United States
Denver Public Health (Site 017-004), 660 Bannock St., MC2600 (Infectious Disease Clinic)
Denver, Colorado, 80204, United States
National Jewish Health / St. Joseph Hospital (Site 204-003), 1400 Jackson Street
Denver, Colorado, 80206, United States
West Haven VA Medical Center (Site 025-007), 950 Campbell Avenue
West Haven, Connecticut, 06516, United States
MedStar Health Research Institute (Site 009-021), MedStar Washington Hospital Center, 110 Irving St., NW.
Washington D.C., District of Columbia, 20010, United States
Washington DC VA Medical Center (Site 009-004), 50 Irving Street NW
Washington D.C., District of Columbia, 20422, United States
Bay Pines VAMC (Site 074-004), 10000 Bay Pines Blvd., Bldg. 100, Room 5B-104
Bay Pines, Florida, 33744, United States
Baycare Health System (Site 301-025), Morton Plant Hospital, 300 Pinellas Street
Clearwater, Florida, 33756, United States
North Florida/South Georgia Veterans Health System (Site 074-011), 1601 SW. Archer Road
Gainesville, Florida, 32608-1197, United States
Memorial Healthcare System (Site 648-002), Memorial Regional Hospital, 3501 Johnson Street
Hollywood, Florida, 33021, United States
Miami VAMC (Site 074-003), 1201 NW 16 Street
Miami, Florida, 33125, United States
Hillsborough County Health Department, University of South Florida (Site 032-001)
Tampa, Florida, 33602, United States
Emory University (Site 301-008), The Emory Clinic, Bldg. A, Suite 2236, 1365 Clifton Rd., NE
Atlanta, Georgia, 30322, United States
Lutheran Medical Group (Site 301-010), 7916 W. Jefferson Boulevard
Fort Wayne, Indiana, 46804, United States
Cotton O'Neil Clinical Research Center (Site 080-030), Stormont Vail Health, 1500 SW 10th Avenue
Topeka, Kansas, 66604, United States
University of Kentucky Hospital (Site 210-004), 1000 South Limestone St.
Lexington, Kentucky, 40536, United States
Ochsner Clinic Foundation (Site 301-015), 1514 Jefferson Highway
New Orleans, Louisiana, 70121, United States
University of Maryland Medical Center (Site 301-019), 22 South Greene Street
Baltimore, Maryland, 21201, United States
Massachusetts General Hospital (Site 202-002), 55 Fruit Street
Boston, Massachusetts, 02114, United States
Beth Israel Deaconess Medical Center (Site 202-001), 330 Brookline Ave.
Boston, Massachusetts, 02215, United States
Baystate Medical Center (Site 201-001), 759 Chestnut Street
Springfield, Massachusetts, 01199, United States
University of Michigan (Site 205-001), 1500 East Medical Center Drive
Ann Arbor, Michigan, 48109, United States
Henry Ford Health System, Henry Ford Hospital (Site 014-001), 2799 W. Grand Blvd.
Detroit, Michigan, 48202, United States
Minneapolis Heart Institute Foundation (Site 301-026), Abbott Northwestern Hospital, 920 E 28th St. #100
Minneapolis, Minnesota, 55407, United States
Hennepin Healthcare (Site 027-001), 701 Park Avenue
Minneapolis, Minnesota, 55415, United States
Minneapolis VA Health Care System (Site 105-001), 1 Veterans Drive, Bldg 70
Minneapolis, Minnesota, 55417, United States
M Health Fairview University of Minnesota Medical Center (Site 112-001), 500 Harvard St. SE.
Minneapolis, Minnesota, 55455, United States
University of Mississippi Medical Center (Site 202-005), 2500 North State Street
Jackson, Mississippi, 39216, United States
Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital (Site 301-024), One Medical Center Drive
Lebanon, New Hampshire, 03756, United States
Cooper University Hospital (Site 019-001), One Cooper Plaza
Camden, New Jersey, 08103, United States
SUNY Downstate Medical Center (Site 033-001), 450 Clarkson Ave.
Brooklyn, New York, 11203, United States
Maimonides Medical Center (Site 033-002), 4802 10th Avenue
Brooklyn, New York, 11219, United States
Lincoln Medical Center (New York Health and Hospitals/Lincoln) (Site 003-016), 234 E. 149th Street
The Bronx, New York, 10451, United States
Montefiore Medical Center Weiler Hospital (Site 206-003), 1825 Eastchester Road
The Bronx, New York, 10461, United States
Montefiore Medical Center Moses Hospital (Site 206-001), 111 E. 210th Street
The Bronx, New York, 10467, United States
Duke University Hospital (Site 301-006), 2301 Erwin Road
Durham, North Carolina, 27710, United States
Wake Forest University Health Sciences (Site 210-001), Medical Center Blvd
Winston-Salem, North Carolina, 27157, United States
University of Cincinnati Medical Center (Site 207-003), 234 Goodman Ave.
Cincinnati, Ohio, 45219, United States
University Hospitals Cleveland Medical Center (Site 108-001), 11100 Euclid Avenue
Cleveland, Ohio, 44106, United States
Cleveland Clinic Fairview Hospital (Site 207-005), 18101 Lorain Avenue
Cleveland, Ohio, 44111, United States
Cleveland Clinic Foundation (Site 207-001), 9500 Euclid Avenue
Cleveland, Ohio, 44195, United States
Cleveland Clinic Marymount Hospital (Site 207-006), 12300 McCraken Road
Garfield Heights, Ohio, 44125, United States
Oregon Health & Science University (Site 208-003), 3181 SW Sam Jackson Park Rd.
Portland, Oregon, 97239-3098, United States
UPMC Magee-Womens Hospital (Site 209-003), 300 Halket Street
Pittsburgh, Pennsylvania, 15213, United States
UPMC Presbyterian Hospital (Site 209-001), 200 Lothrop Street
Pittsburgh, Pennsylvania, 15213, United States
UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue
Pittsburgh, Pennsylvania, 15232, United States
Rhode Island Hospital (Site 080-036), 593 Eddy Street
Providence, Rhode Island, 02903, United States
The Miriam Hospital (Site 080-039), 164 Summit Ave.
Providence, Rhode Island, 02906, United States
VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave.
Providence, Rhode Island, 02908, United States
Ralph H. Johnson VA Medical Center (Site 074-015), 109 Bee Street
Charleston, South Carolina, 29401, United States
MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214
Charleston, South Carolina, 29425, United States
MUSC Health Florence Medical Center (Site 210-006), 805 Pamplico Highway
Florence, South Carolina, 29505, United States
VA TVHS Nashville Campus (Site 074-022), 1310 24th Avenue South
Nashville, Tennessee, 37212, United States
Vanderbilt University Medical Center (Site 212-001), 1211 Medical Center Drive
Nashville, Tennessee, 37232, United States
Hendrick Medical Center (Site 080-014), 1900 Pine Street
Abilene, Texas, 79601, United States
CHRISTUS Spohn Shoreline Hospital (Site 080-001), 600 Elizabeth Street
Corpus Christi, Texas, 78404, United States
Parkland Health and Hospital Systems (Site 084-002), 5200 Harry Hines Blvd
Dallas, Texas, 75235, United States
UT Southwestern Medical Center (Site 084-001), 1936 Amelia Court, 2nd Floor
Dallas, Texas, 75235, United States
Baylor, Scott and White Health (Site 301-003), Baylor University Medical Center, 3500 Gaston Ave.
Dallas, Texas, 75246, United States
Michael E. DeBakey Veterans Affairs Medical Center (MEDV AMC) (Site 074-006), 2002 Holcombe Blvd.
Houston, Texas, 77030, United States
Texas Heart Institute (Site 301-017), 6770 Bertner, MC4-266
Houston, Texas, 77030, United States
CHRISTUS Good Shepherd Medical Center (Site 080-031), 700 E. Marshall Ave.
Longview, Texas, 75601, United States
Intermountain Medical Center (Site 211-001), 5121 South Cottonwood Street
Murray, Utah, 84107, United States
University of Utah Hospital (Site 211-002), 419 Wakara Way, Suite 207
Salt Lake City, Utah, 84108, United States
LDS Hospital (Site 211-004), 8th Ave. C Street
Salt Lake City, Utah, 84143, United States
University of Virginia Health Systems (Site 301-021), 1215 Lee Street
Charlottesville, Virginia, 22903, United States
Carilion Roanoke Memorial Hospital (Site 080-018), 1906 Belleview Avenue
Roanoke, Virginia, 24014, United States
Salem VA Medical Center (Site 074-014), 1970 Roanoke Blvd.
Salem, Virginia, 24153, United States
Swedish Hospital First Hill (Site 208-005), 747 Broadway
Seattle, Washington, 98122, United States
West Virginia University (Site 301-023), One Medical Center Drive
Morgantown, West Virginia, 26506, United States
Aalborg Hospital (Site 625-005), Hobrovej 18
Aalborg, 9000, Denmark
Aarhus Universitetshospital, Skejby (Site 625-002), Department of Infectious Diseases, Palle Juul-Hensens Boulevard 99
Aarhus N, 8200, Denmark
Bispebjerg Hospital (Site 625-013), Bispebjerg Bakke 23
Copenhagen, 2400, Denmark
Righospitalet (Site 625-006), Blegdamsvej 9,
Copenhagen Ø, 2100, Denmark
Herlev/Gentofte Hospital (Site 625-012), Medicinsk Afdeling, Herlev Ringvej 75
Herlev, 2730, Denmark
Nordsjællands Hospital (Site 625-009), Dyrehavevej 29
Hillerød, 3400, Denmark
Hvidovre University Hospital, Department of Infectious Diseases (Site 625-001), Kettegård allé 30
Hvidovre, 2650, Denmark
Kolding Sygehus (Site 625-011), Medicinsk Afdeling, Sygehusvej 24
Kolding, 6000, Denmark
Odense University Hospital (Site 625-004), Infektionsmedicinsk Forskningsenhed, J.B. Winsløwsgade 4
Odense, 5000, Denmark
Zealand University Hospital, Roskilde (Site 625-010), Sygehusvej 10
Roskilde, 4000, Denmark
Democritus University of Thrace (Site 635-021), University General Hospital of Alexandroupolis, Dragana
Alexandroupoli, Evros, 68131, Greece
Evangelismos COVID-19 Unit, (Site 635-020), 1st Dept. of Pulmonary and Critical Care Medicine, Evangelismos General Hospital, Dept., Ipsilantou 45-47
Athens, 106 76, Greece
1st Respiratory Medicine Dept., Athens University Medical School (Site 635-015), Athens Hospital for Diseases of the Chest "Sotiria Hospital", 152 Mesogeion Ave.
Athens, 115 27, Greece
3rd Dept. of Medicine, Medical School, NKUA (Site 635-022), Sotiria General Hospital, 152 Mesogeion Ave.
Athens, 115 27, Greece
Attikon University General Hospital (Site 635-009), 4th Dept. of Internal Medicine, Medical School, National and Kapodistrian University of Athens, 1 Rimini St., Haidari
Athens, 124 62, Greece
Wojewódzki Szpital Zakazny (Site 625-302), Wolska 37
Warsaw, 01-201, Poland
Tan Tock Seng Hospital (Site 612-201), National Centre for Infectious Diseases (NCID), 11 Jalan Tan Tock Seng
Singapore, 308433, Singapore
Hospital Universitari Germans Trias i Pujol (Site 626-003), Infectious Disease Unit, Second Floor, Building Maternal, Road Canyet s/n
Badalona, Barcelona, 08916, Spain
Hospital Universitari Arnau de Vilanova (Site 626-035), Av. Alcalde Rovira Roure 80
Lleida, Leida, 25198, Spain
Hospital Del Mar (Site 626-025), Paseo Maritimo 25-29
Barcelona, 08003, Spain
Hospital Universitari Vall d'Hebron (Site 626-033), Passeig de la Vall d'Hebron 119-129
Barcelona, 08035, Spain
Hospital Clínic de Barcelona (Site 626-004), Carrer de Villaroel 170
Barcelona, 08036, Spain
Hospital Universitario de Bellvitge (Site 626-034), Carrer de la Feixa Llarga, s/n
Barcelona, 08907, Spain
Hospital General Universitario Gregorio Marañón (Site 626-001), Dr. Esquerdo, 46
Madrid, 28017, Spain
Hospital Clínico San Carlos (Site 626-017), Enfermedades infecciosas, C/Martin Lagos CN
Madrid, 28040, Spain
UCICEC (Clinical Trial Unit) Hospital Universitario La Paz (Site 626-012), Paseo de la Castellana 261, 2a planta Hospital Maternal
Madrid, 28046, Spain
University Hospital Zurich (Site 621-201), Department of Infectious Diseases and Hospital Epidemiology, Raemistrasse 100
Zurich, Canton of Zurich, 8091, Switzerland
MRC/UVRI and LSHTM Uganda Research Unit (Site 634-601), Entebbe Regional Referral Hospital
Entebbe, Uganda
Gulu Regional Referral Hospital (Site 634-603), Laroo Division, PO Box 160
Gulu, Uganda
Makerere University Lung Institute (Site 634-604), New Mulago Hospital Complex, Mulago Hill
Kampala, Uganda
St. Francis Hospital, Nsambya (Site 634-607), Nsambya Road Nsambya Hill, P.O. Box 7146
Kampala, Uganda
Lira Regional Referral Hospital (Site 634-605)
Lira, Uganda
Masaka Regional Referral Hospital (Site 634-606), MRC/UVRI and LSHTM Uganda Research Unit, Plot 6 Circle Road, PO Box 556
Masaka, Uganda
Royal Victoria Infirmary (Site 634-007), Queen Victoria Road
Newcastle upon Tyne, Northumbria, NE1 4LP, United Kingdom
Royal Free Hospital (Site 634-006), Pond Street, Hampstead
London, NW3 2QG, United Kingdom
Guy's and St. Thomas' NHS Foundation Trust (Site 634-011)
London, SE1 7EH, United Kingdom
Related Publications (1)
ACTIV-3-Therapeutics for Inpatients with COVID-19 (TICO) Study Group. Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial. Lancet Respir Med. 2022 Oct;10(10):972-984. doi: 10.1016/S2213-2600(22)00215-6. Epub 2022 Jul 8.
PMID: 35817072RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Greg Grandits
- Organization
- University of Minnesota
Study Officials
- PRINCIPAL INVESTIGATOR
Jens Lundgren, Prof.
INSIGHT Copenhagen International Coordinating Centre, Rigshospitalet, University of Copenhagen
- STUDY CHAIR
James Neaton, Prof.
INSIGHT Statistical and Data Management Center, University of Minnesota
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2023
First Posted
March 22, 2023
Study Start
February 10, 2021
Primary Completion
January 28, 2022
Study Completion
June 9, 2023
Last Updated
February 4, 2025
Results First Posted
July 30, 2024
Record last verified: 2025-01